Economic impact of prior authorization policies for atypical antipsychotics in the treatment of schizophrenia.

Abouzaid S, Jutkowitz E, Foley KA, Pizzi LT, Kim E, Bates J. Economic impact of prior authorization policies for atypical antipsychotics in the treatment of schizophrenia. Popul Health Manag. 2010 Oct; 13(5):247-54.

View in: PubMed